Target Global Acquisition I (NASDAQ:TGAA) and Moolec Science (NASDAQ:MLEC) Critical Contrast

Target Global Acquisition I (NASDAQ:TGAA) and Moolec Science (NASDAQ:MLEC) are both small-cap unclassified companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, institutional ownership, earnings, valuation and profitability.

Analyst Ratings

This is a summary of recent recommendations for Target Global Acquisition I and Moolec Science, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Target Global Acquisition I	0	0	0	0	0.00
Moolec Science	0	0	1	0	3.00

Moolec Science has a consensus target price of $6.00, suggesting a potential upside of 650.09%. Given Moolec Science’s stronger consensus rating and higher probable upside, analysts plainly believe Moolec Science is more favorable than Target Global Acquisition I.

Institutional and Insider Ownership

92.1% of Target Global Acquisition I shares are held by institutional investors. Comparatively, 0.1% of Moolec Science shares are held by institutional investors. 41.4% of Target Global Acquisition I shares are held by insiders. Comparatively, 19.9% of Moolec Science shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Target Global Acquisition I and Moolec Science’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Target Global Acquisition I	N/A	N/A	N/A
Moolec Science	-129.97%	-97.95%	-27.91%

Valuation & Earnings

This table compares Target Global Acquisition I and Moolec Science”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Target Global Acquisition I	N/A	N/A	N/A	N/A	N/A
Moolec Science	$5.63 million	5.47	-$7.31 million	($0.20)	-4.00

Target Global Acquisition I has higher earnings, but lower revenue than Moolec Science.

Volatility and Risk

Target Global Acquisition I has a beta of 0.01, meaning that its stock price is 99% less volatile than the S&P 500. Comparatively, Moolec Science has a beta of -0.49, meaning that its stock price is 149% less volatile than the S&P 500.

Summary

Target Global Acquisition I beats Moolec Science on 6 of the 10 factors compared between the two stocks.

About Target Global Acquisition I

Target Global Acquisition I Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on companies operating in the consumer internet, mobility, and financial technology sectors. The company was incorporated in 2021 and is based in Grand Cayman, the Cayman Islands.

About Moolec Science

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.